• Boracay Hotels
• Cebu Hotels
• Free Articles Submissions

Bali Hotels

Web Related Articles

• FDA Panel Urges Approval of Hepatitis C Drug

In an 18-0 vote, an FDA advisory panel recommended approval of the drug boceprevir to treat hepatitis C....

• FDA Panel Urges Approval of Hepatitis C Drug

In an 18-0 vote, an FDA advisory panel recommended approval of the drug boceprevir to treat hepatitis C....

• Hepatitis C Drug Telaprevir Raises Cure Rate

Adding the experimental hepatitis C drug telaprevir to standard interferon/ribavirin therapy cured 75% of newly treated patients and shortened treatment time, drug maker Vertex announced....

• Hepatitis ABC

It's important to know your Hepatitis ABC risk. Hepatitis AB or C is another silent but deadly killer. May 19th marked world Hepatitis day. President Obama acknowledges the issue....

• New Drug Cures Hard-to-Treat Hepatitis C

Many hepatitis C patients who had failed standard treatment were cured when the drug telaprevir was given....

• Neonatal Hepatitis

Hepatitis is an inflammation of the liver that can be caused by numerous viruses, diseases or environmental conditions that cause the liver to become inflamed. When hepatitis occurs in infancy, this is called "neonatal hepatitis"....

• New Hepatitis C Drug Incivek Gets FDA Approval

The FDA has approved Incivek as an add-on to current interferon/ribavirn therapy for hepatitis C infection. Like Victrelis, also approved this month, Incivek greatly boosts the cure rate for hepatitis C....

• More Now Die in U.S. From Hepatitis C Than HIV

More Americans die as a result of hepatitis C infection annually than from HIV-related causes, pointing out the need for expanded screening and improved access to care for hepatitis C, government researchers report....

• FDA Panel Backs 2 Hepatitis C Drugs

A major advance for treating hepatitis C is likely headed to market after government advisors backed two new drugs: telaprevir and boceprivir....

• FDA Panel Backs 2 Hepatitis C Drugs

A major advance for treating hepatitis C is likely headed to market after government advisors backed two new drugs: telaprevir and boceprivir....

• Experts Propose Age-Based Hepatitis C Testing

Screening all people born between 1946 and 1970 for the hepatitis C virus would greatly reduce the number of people with advanced liver disease linked with the virus, according to new research....

• Experts Propose Age-Based Hepatitis C Testing

Screening all people born between 1946 and 1970 for the hepatitis C virus would greatly reduce the number of people with advanced liver disease linked with the virus, according to new research....

• Liver-Targeted Drug Stops Hepatitis C

A durable DNA molecule that blocks tiny RNA molecules in the liver safely keeps hepatitis C virus in check, chimp studies find. A human study is under way....

• 3-Drug Combo May Treat Hepatitis C

Two highly anticipated hepatitis C drugs are poised to usher in a new era in the treatment of the viral disease as early as this summer, experts say....

• Hepatitis C Alternative Treatments

Experts lay out the pros and cons of herbal remedies and other alternative treatments for hepatitis C....

• New Hepatitis C Drugs in the Works

In early research, a combination of two experimental, antiviral drugs dramatically reduced levels of hepatitis C virus in the blood of infected patients over two weeks of treatment....

• Experimental Drug May Treat Hepatitis C

An experimental oral drug is showing early promise for the treatment of chronic hepatitis C virus (HCV) infection, a study shows....

• Hepatitis A & B Vaccines: Why You Should Get Them

Learn how hepatitis A and B vaccines protect you from the viruses that can lead to this liver disease....

• Hepatitis C Infection Rates Are Stable

The incidence of new hepatitis C virus (HCV) infections in the U.S. declined by more than 90% between 1990 and 1992 and has remained relatively stable ever since, new figures from the CDC confirm....

• Signs of Rise in Hepatitis C Cases Among Young

Hepatitis C infections are rising among adolescents and young adults in Massachusetts, apparently in part due to needle sharing that spreads the virus, the CDC says in a new report....

• ‘Explosion’ of Sex-Spread Hepatitis C in HIV-Positive Men

There is an ongoing "explosion" of deadly hepatitis C among men who have sex with men. It's spread mainly by anal sex, often enhanced by methamphetamine, according to a CDC report....

• New Hepatitis C Drug Victrelis (Bocepravir) Approved by FDA

The FDA has approved Victrelis (bocepravir) to treat hepatitis C....

• What Are Clinical Trials For?

Clinical trials are a product of the Food and Drug Administration of the United States government. The FDA is in charge of regulating and approving all of the drugs that come to market in the US. In order to do that, it has created an approval process that takes up to a decade for many drugs. What does this mean for you, the average consumer?...

• Hepatitis B Drug Fights Liver Fibrosis, Cirrhosis

A new generation of antiviral drugs can help reverse liver fibrosis and even early cirrhosis in patients with chronic hepatitis B virus infection, and they continue to work for many years, new research suggests....

• Panel Recommends Hepatitis B Vaccine for Diabetes Patients

By a 12-2 vote, the Advisory Committee on Immunization Practices strongly recommended the hepatitis B vaccine for diabetes patients under age 60 who have not been fully vaccinated....

• Combination Therapy May Treat Prostate Cancer

For some men with early-stage prostate cancer, adding short-term hormone treatment to radiation therapy improves their chances of survival, according to a new study....

• Leukemia Treatment Breakthrough

Adding Rituxan to standard chemotherapy for chronic lymphocytic leukemia raises three-year survival to 65% and is now the gold standard therapy for most patients....

• Many Patients Don’t Take Part in Cancer Studies

Just an estimated 2% to 4% of adults who are newly diagnosed with cancer participate in clinical trials even though there are more than 8,000 such trials that are actively recruiting....